Abstract
ABSTRACT: Current guidelines for heparin therapy in pediatric patients have been extrapolated from trials in adult patients without rigorous evaluation of efficacy and safety. We prospectively monitored consecutive pediatric patients receiving systemic doses of heparin over 10 mo at one institution using a predetermined nomogram to monitor maintenance therapy. Sixty-five consecutive children; 38 males and 27 females, received systemic doses of heparin. Thirty children had deep venous thrombosis and/or pulmonary embolism; 11 had arterial thrombi, most frequently after diagnostic angiography; and the remaining 24 received heparin prophylactically, for congenital heart disease. Twenty-nine (45%) of the 65 patients were less than 1 y of age and 22 (34%) were 10 y or older. Congenital heart disease was the predominant diagnosis under 1 y and deep venous thrombosis in older children. After a bolus dose of 50 U/kg, 39% of children (n = 30) achieved a minimal level activated partial thromboplastin time (APTT). Sixty-eight percent of children achieved a minimal level APTT by 24 h and 81% by 48 h. For all 65 children, APTT values were within the therapeutic range 43% of the time. APTT values outside the therapeutic range were twice as likely to be low as high. The average amount of heparin required to maintain therapeutic APTT values for children was 22 U/kg/h: 28 U/kg/h for infants <1 y and 20 U/kg/h for the rest. Bleeding was rare (2%) and mild. Documented recurrent thrombotic disease was more common (7%) with associated morbidity. In summary, a commonly used protocol for administration of heparin to children was rigorously evaluated and shown to provide insufficient amounts of heparin in the first days of treatment. Average requirements of heparin per kilogram per hour were determined and will form the bases of future studies.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andrew, M., Marzinotto, V., Massicotte, P. et al. Heparin Therapy in Pediatric Patients: A Prospective Cohort Study. Pediatr Res 35, 78–83 (1994). https://doi.org/10.1203/00006450-199401000-00016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199401000-00016
This article is cited by
-
Challenges and Opportunities in the Pharmacological Treatment of Acute Venous Thromboembolism in Children
Pediatric Drugs (2020)
-
Development and Implementation of a Standardized Heparin Protocol for Left-Sided Pediatric Electrophysiology Procedures
Pediatric Cardiology (2018)
-
Consider dosing, monitoring and complications when using anticoagulants to treat acute venous thromboembolism in paediatric patients
Drugs & Therapy Perspectives (2015)
-
A Guide to the Use of Anticoagulant Drugs in Children
Pediatric Drugs (2015)
-
Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric Patients
Clinical Pharmacokinetics (2013)